Tradestie Institutional Equity Comparison Engine

RSPR vs RSPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RSPH Overall Edge

RSPH Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco S&P 500 Equal Weight Health Care ETF (RSPH) driven by superior Momentum & Technical. Fundamentally, RSPR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RSPH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RSPR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against RSPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RSPR N/M vs RSPH N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RSPH
1Y +6.7% vs +30.6% ยท 52W Pos 62% vs 91%
Options & Structure Winner Tie
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
RSPR NYSE Arca
Invesco S&P 500 Equal Weight Real Estate ETF
Institutional Equity
$35.88
-0.24% 1D
Market Cap N/A
1M Return +5.13%
1Y Return +6.69%
Forward P/E N/M
Unified AI Score
31.7 / 100 SELL
Tech 41.0 Fund 37.0 Flow 50.0 Mom 21.1
RSPH NYSE Arca
Invesco S&P 500 Equal Weight Health Care ETF
Institutional Equity
$40.85
-0.44% 1D
Market Cap N/A
1M Return +5.31%
1Y Return +30.59%
Forward P/E N/M
Unified AI Score
43.6 / 100 HOLD
Tech 25.0 Fund 34.0 Flow 50.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RSPR +6.69% RSPH +30.59% Spread: +23.9 pp (RSPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RSPR TTM Op. Margin: N/A RSPH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RSPR vs RSPH. Trailing 12-month operating profitability (RSPR N/A vs RSPH N/A) and valuation multiples (RSPR N/M vs RSPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RSPR (0) vs RSPH (3)
Institutional Metric RSPR RSPH Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 62% ($32โ€“$38) 91% ($30โ€“$42) Stronger Trend RSPH
Beta / 30D Volatility Risk Regime 0.29ฮฒ ยท 22% Vol 0.44ฮฒ ยท 20% Vol Lower Realized Risk RSPH
Unified Institutional Score Composite Signal 31.7 / 100 (SELL) 43.6 / 100 (HOLD) Higher Composite RSPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RSPR vs RSPH Buy Guide
RSPR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RSPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RSPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RSPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RSPR nor RSPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.